Bob Herman / Axios
Context
- CMS announces 1,750 insurance plans have agreed to cap insulin costs for Medicare Advantage and Part D members at $35/month; Drugmakers have also agreed to the plan (Robert King / Fierce Healthcare)
- Eli Lilly caps insulin cost at $35 per month amid COVID-19 pandemic (Becker’s Hospital Review)